Forte Biosciences, Inc.

NASDAQ
FBRX
Stock
Yield per half year: -55.46%
Dividend yield: 0%
Sector: Healthcare

9.67 $

0 $ 0%
0.3 $
28 $

Min/max per year

Share chart Forte Biosciences, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Forte Biosciences, Inc.

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date 2017-04-13
ISIN US34962G1094
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт link
Change price per day: 0% (9.67)
Change price per week: +28.59% (7.52)
Change price per month: +31.69% (7.343)
Change price per 3 month: +3.98% (9.3)
Change price per half year: -55.46% (21.71)
Change price per year: +1 447.2% (0.625)
Change price per 3 year: +705.83% (1.2)
Change price per 5 year: +705.83% (1.2)
Change price per year to date: -55.02% (21.5)
All parameters

Grade

Underestimation
Title Value Grade
P/S 0 0
P/BV 1.26 9
P/E 0 0
Efficiency
Title Value Grade
ROA, % -70.57 0
ROE, % -80.82 0
ROIC, % 0 0
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0 0
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA 0 10
Debt/Ratio 0 10
Debt/Equity 0.173 10
Growth impulse
Title Value Grade
Yield Revenue, % -29.41 0
Yield Ebitda, % -297.98 0
Yield EPS, % 14.03 3
More

Main owners

Institutions Volume Share, %
Tybourne Capital Management (HK) Limited 3 624 548 9.96
Perceptive Advisors LLC 3 265 359 8.97
BVF Inc. 2 982 105 8.19
Cable Car Capital LLC 2 031 987 5.58
Fred Alger Management, LLC 1 838 965 5.05
Farallon Capital Management Llc 1 810 455 4.97
Bml Capital Management, LLC 1 761 702 4.84
Vanguard Group Inc 665 230 1.83
Geode Capital Management, LLC 336 605 0.92
Blackrock Inc. 182 324 0.5

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Dr. Paul A. Wagner Ph.D. CEO, President & Chairman 960.23k 1970 (55 years)
Mr. Christopher Roenfeldt Chief Operating Officer N/A
Mr. Steven Ruhl Chief Technical Officer N/A 1957 (68 years)
Mr. Antony A. Riley CPA Chief Financial Officer 568.48k 1967 (58 years)
Dr. Barbara K. Finck M.D. Chief Medical Clinician & Director 45k 1947 (78 years)

About company

Address: United States, Dallas. TX, 3060 Pegasus Park Drive - Open in google maps, Open in yandex maps
Website: https://www.fortebiorx.com